Session Name: Hidradenitis Suppurativa for APPs - from Primary to Specialty Care

Time: November 12, 2025

We appreciate your time and effort in participating in this CME Sessional Evaluation. This evaluation is a pipeline to bring your voice to the leadership, instructors, and CME team. We value your voice and try our best to improve the quality of future activities.

*
*
Did/Will you use this information for specific patient(s)?
What patient/health care problem recently challenged you, and you wish you knew more about?
Comments and Feedback on the learning experience, content, procedure, and instructors, etc. in this session.
As a result of my participation in this activity, I am better able to... 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly disagree
1234
Diagnose hidradenitis suppurativa (HS) at all stages including initial care or stabilization and referral. Review HS diagnosis in multiple stages and in multiple skin tones.
Understand the basic differential for HS. Review differential including infectious abscess, epidermal inclusion cyst, cutaneous Crohns, etc.
Prescribe single and combination treatments for HS patients for maintenance or flare care. Review initial management for mild to moderate HS including topicals, systemics, hormonal therapy. For specialists or ER/urgent care, will review flare treatment options and appropriate referral pathways.
Support HS patients with empathic and appropriate care. HS patients often suffer from delayed diagnosis, lack of care, stigma, increased mental health comorbidities. We will discuss empathic and appropriate care for HS patients to ensure high quality care for HS patients.
The following speaker(s) demonstrated experiential knowledge of the topic 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
Gretchen Roth, MD
Choose the option that best fits your evaluation of this activity: 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
The content provided a fair and balanced coverage of the topic
The content was free of commercial bias